Skip to content
HowShorted

Corvus Pharmaceuticals, Inc. short interest in 2026

In 2026, Corvus Pharmaceuticals, Inc.'s disclosed short interest ran from 15.38% of shares outstanding on 15 Jan 2026 to 20.42% on 15 Sep 2026, a change of +5.04 percentage points. The year's high was 22.74% on 14 Aug 2026 and its low 15.38% on 15 Jan 2026, averaging 20.80% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 29.64 days on 31 Aug 2026. Full history: Corvus Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Corvus Pharmaceuticals, Inc. in 2026

2026 in figures

Start of year
15.38% (15 Jan 2026)
End of year
20.42% (15 Sep 2026)
Change
+5.04 pp
High
22.74% (14 Aug 2026)
Low
15.38% (15 Jan 2026)
Average
20.80%
Highest days to cover
29.64 (31 Aug 2026)
SEC filings marked
6

Every report in 2026

Corvus Pharmaceuticals, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202615.38%7.54
30 Jan 202619.65%1.09
13 Feb 202619.93%9.81
27 Feb 202621.44%13.29
13 Mar 202619.11%14.7110-K filed, results (8-K)
31 Mar 202620.18%11.09
15 Apr 202620.15%21.77
30 Apr 202621.89%11.54
15 May 202622.51%11.9810-Q filed, results (8-K)
29 May 202620.63%8.45
15 Jun 202621.29%14.37
30 Jun 202622.41%12.38
15 Jul 202621.50%12.59
31 Jul 202621.80%22.50
14 Aug 202622.74%22.5310-Q filed, results (8-K)
31 Aug 202622.61%29.64
15 Sep 202620.42%18.16

See also: Corvus Pharmaceuticals, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.